Loading candles…
Indo US Bio-Tech Ltd, incorporated in 2004, operates within the agriculture and seed production industries. The company specializes in producing and processing commercial and vegetable seeds. It focuses on developing, processing, and marketing high-performing seeds through its own research stations and production bases. These facilities concentrate on breeding seed varieties resilient to diverse climatic conditions and diseases. Indo US Bio-Tech Ltd is an ISO-certified agricultural seed company that supplies high-yield seeds to farmers across various regions, contributing to national food security.
This page is a live market overview for INDO US BIOTECH LTD (INDOUS) on the NSE. As a listed security, INDO US BIOTECH LTD is tracked in the Fast Moving Consumer Goods segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INDOUS before placing trades on tick2trade.
As of the latest feed, INDOUS last traded at ₹81.65 on NSE, up ₹1.3 (1.62%) from the previous close of ₹80.35. Today's session range is ₹80.75 – ₹84, against a 52-week band of ₹80.1 – ₹182.1. Traded volume today stands at 18.52K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for INDOUS in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INDOUS is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INDO US BIOTECH LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INDOUS. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INDOUS option chain page linked from this overview.
| Details |
|---|
| Date |
|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 12 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 29 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 21 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 14 Nov 2025 |
| Intimation | Notice is hereby given pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( LODR ) that a meeting of t… | 14 Oct 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 26 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.